New York State Common Retirement Fund’s Stemline Therapeutics, Inc. STML Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-35,900
| Closed | -$174K | – | 3360 |
|
|
2020
Q1 | $174K | Hold |
35,900
| – | – | ﹤0.01% | 2526 |
|
|
2019
Q4 | $382K | Sell |
35,900
-11,600
| -24% | -$115K | ﹤0.01% | 2429 |
|
|
2019
Q3 | $494K | Buy |
47,500
+9,000
| +23% | +$118K | ﹤0.01% | 2341 |
|
|
2019
Q2 | $590K | Buy |
38,500
+7,000
| +22% | +$101K | ﹤0.01% | 2287 |
|
|
2019
Q1 | $405K | Hold |
31,500
| – | – | ﹤0.01% | 2400 |
|
|
2018
Q4 | $299K | Hold |
31,500
| – | – | ﹤0.01% | 2523 |
|
|
2018
Q3 | $523K | Hold |
31,500
| – | – | ﹤0.01% | 2392 |
|
|
2018
Q2 | $506K | Buy |
31,500
+7,400
| +31% | +$132K | ﹤0.01% | 2447 |
|
|
2018
Q1 | $369K | Buy |
24,100
+5,900
| +32% | +$92K | ﹤0.01% | 2486 |
|
|
2017
Q4 | $284K | Hold |
18,200
| – | – | ﹤0.01% | 2609 |
|
|
2017
Q3 | $202K | Hold |
18,200
| – | – | ﹤0.01% | 2771 |
|
|
2017
Q2 | $167K | Sell |
18,200
-17,716
| -49% | -$148K | ﹤0.01% | 2929 |
|
|
2017
Q1 | $307K | Buy |
35,916
+4,716
| +15% | +$43K | ﹤0.01% | 2612 |
|
|
2016
Q4 | $334K | Hold |
31,200
| – | – | ﹤0.01% | 2551 |
|
|
2016
Q3 | $338K | Hold |
31,200
| – | – | ﹤0.01% | 2524 |
|
|
2016
Q2 | $211K | Hold |
31,200
| – | – | ﹤0.01% | 2705 |
|
|
2016
Q1 | $145K | Hold |
31,200
| – | – | ﹤0.01% | 2811 |
|
|
2015
Q4 | $197K | Hold |
31,200
| – | – | ﹤0.01% | 2782 |
|
|
2015
Q3 | $275K | Sell |
31,200
-2,296
| -7% | -$24.1K | ﹤0.01% | 2615 |
|
|
2015
Q2 | $394K | Buy |
33,496
+16,496
| +97% | +$229K | ﹤0.01% | 2621 |
|
|
2015
Q1 | $246K | Buy |
+17,000
| New | +$260K | ﹤0.01% | 2128 |
|
New York State Common Retirement Fund's STML Position: Q2 2020 in Review
New York State Common Retirement Fund sold out of Stemline Therapeutics, Inc. (STML) in Q2 2020, closing a stake of 35,900 shares — an estimated $174K sold.
New York State Common Retirement Fund first reported a position in STML in Q1 2015 and held it in 21 quarters. The position peaked at $590K in Q2 2019. 0 funds tracked by Wall St. Rank hold STML as of Q2 2020.
- New York State Common Retirement Fund reported no remaining Stemline Therapeutics, Inc. position as of Q2 2020 after selling out during the quarter.
- New York State Common Retirement Fund sold 35,900 Stemline Therapeutics, Inc. shares in Q2 2020, an estimated $174K.
- New York State Common Retirement Fund first reported a position in Stemline Therapeutics, Inc. in Q1 2015 and held it in 21 quarters.
- New York State Common Retirement Fund's Stemline Therapeutics, Inc. position peaked at $590K in Q2 2019.
- 0 funds tracked by Wall St. Rank held Stemline Therapeutics, Inc. as of Q2 2020.
Based on New York State Common Retirement Fund's 13F filing for Q2 2020, filed 7 Aug 2020.